The bill, S.B. No. 1867, proposes amendments to the Texas Controlled Substances Act by adding a variety of new substances to Penalty Group 2. This includes numerous hallucinogenic compounds, synthetic cannabinoids, and other psychoactive substances. Notably, the bill introduces specific chemical names and trade names for these substances, such as 5-(2-aminopropyl)benzofuran (5-APB), 1-pentyl-3-(1-naphthoyl) indole (JWH-018), and various tetrahydrocannabinols, among others. The amendments aim to address the evolving landscape of drug use and ensure that new synthetic drugs are classified under the law to prevent abuse.

Additionally, the bill modifies existing language by replacing the phrase "or" with "delta-5, cis or trans tetrahydrocannabinol," and adds multiple new tetrahydrocannabinol variants and their optical isomers to the list of controlled substances. The changes will take effect on September 1, 2025, and apply only to offenses committed after that date, ensuring that any offenses occurring before the effective date will be governed by the previous law. This legislative action reflects a proactive approach to drug regulation in Texas, aiming to keep pace with emerging substances that pose risks to public health and safety.

Statutes affected:
Introduced: Health and Safety Code 481.103 (Health and Safety Code 481)